Copyright © 2005 American Medical Association. All rights reserved. From: Expanding Indications for Statins in Cerebral IschemiaA Quantitative Study Arch Neurol. 2005;62(1):67-72. doi:10.1001/archneur.62.1.67 Figure Legend: Percentage of patients with ischemic stroke and transient ischemic attack who met criteria for mandated and optional initiation of statin therapy, according to various panel guidelines, the Heart Protection Study (HPS) trial, the HPS-based US Food and Drug Administration (FDA) labeling, and an atherosclerotic stroke mechanism algorithm (ASMA). EJTF II indicates European Joint Task Force II; NCEP-ATP III, National Cholesterol Education Program–Adult Treatment Panel III. Date of download: 10/17/2017 Copyright © 2005 American Medical Association. All rights reserved.